EMA Application withdrawn: Hydrocortisone Aguettant (hydrocortisone) — Laboratoire Aguettant

View source ↗

Summary

The European Medicines Agency has withdrawn the marketing authorization application for Hydrocortisone Aguettant (hydrocortisone) by Laboratoire Aguettant for b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Hydrocortisone Aguettant (hydrocortisone)

Snippet

Status: Application withdrawn. Therapeutic area: Bronchopulmonary Dysplasia. MAH: Laboratoire Aguettant